Covered recipient · General Payments record
JENNIFER SZURGOT
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,328.63
- Reported across 153 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $379.02 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $145.57 | 3 |
| Amgen Inc. | $58.53 | 4 |
| Daiichi Sankyo Inc. | $48.32 | 2 |
| Astellas Pharma US Inc | $38.14 | 2 |
| ABIOMED | $30.37 | 1 |
| GlaxoSmithKline, LLC. | $27.14 | 2 |
| Exact Sciences Corporation | $16.84 | 1 |
| Grifols USA, LLC | $14.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $30.37 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142299159 | CMS |
| Amgen Inc. | $14.76 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111720433 | CMS |
| Amgen Inc. | $14.91 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117395184 | CMS |
| Amgen Inc. | $15.39 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117395186 | CMS |
| Amgen Inc. | $13.47 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117395188 | CMS |
| Astellas Pharma US Inc | $17.56 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139327538 | CMS |
| Astellas Pharma US Inc | $20.58 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139397169 | CMS |
| Daiichi Sankyo Inc. | $28.81 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089488418 | CMS |
| Daiichi Sankyo Inc. | $19.51 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089488416 | CMS |
| Exact Sciences Corporation | $16.84 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114926400 | CMS |
| GlaxoSmithKline, LLC. | $13.16 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116377766 | CMS |
| GlaxoSmithKline, LLC. | $13.98 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116719713 | CMS |
| Grifols USA, LLC | $14.11 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124752175 | CMS |
| Lilly USA, LLC | $9.85 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135042744 | CMS |
| Lilly USA, LLC | $10.72 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135042746 | CMS |
| Lilly USA, LLC | $125.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135063047 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.